A study on hepatocellular carcinoma found that SLFN11 deficiency can enhance the infiltration of immunosuppressive macrophages and promote their transformation to the M2-like phenotype by activating the Ccl2 signaling pathway, thereby exacerbating tumor progression (34). Here, SLFN11 is linked to hepatocellular carcinoma.